QRG Capital Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS

Key Points

• QRG Capital Management increased its CVS Health position by 90% in the second quarter, ending with 185,242 shares valued at approximately $19.2 million. Institutional investors and hedge funds collectively own 80.66% of CVS shares.
• Analyst sentiment remains favorable, with 22 analysts rating CVS a Buy and one rating it a Hold. The stock has an average price target of $107.24, although shares recently traded down 1.5% to $85.84.
• CVS reported stronger-than-expected quarterly results, with earnings of $2.58 per share and revenue of $106.1 billion, while maintaining fiscal 2026 EPS guidance of $7.90–$8.10. The company also pays a quarterly dividend of $0.665 per share, equivalent to a 3.1% yield.

QRG Capital Management Inc. raised its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 90.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 185,242 shares of the pharmacy operator's stock after purchasing an additional 87,757 shares during the quarter. QRG Capital Management Inc.'s holdings in CVS Health were worth $19,163,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of CVS. BlackRock Inc. acquired a new stake in CVS Health during the 2nd quarter valued at approximately $12,747,462,000. Norges Bank acquired a new position in shares of CVS Health in the 4th quarter valued at $1,666,265,000. State Street Corp boosted its holdings in CVS Health by 26.3% during the second quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator's stock worth $7,751,205,000 after buying an additional 15,604,883 shares in the last quarter. Bank of America Corp DE increased its holdings in CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator's stock valued at $2,398,868,000 after buying an additional 13,836,701 shares in the last quarter. Finally, Pzena Investment Management LLC acquired a new position in CVS Health in the 2nd quarter worth about $1,217,558,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Argus increased their price objective on shares of CVS Health from $104.00 to $114.00 and gave the company a "buy" rating in a report on Wednesday, August 19th. HSBC reaffirmed a "hold" rating and issued a $103.00 target price on shares of CVS Health in a research note on Monday, July 6th. JPMorgan Chase & Co. upped their price objective on CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a report on Wednesday, August 12th. Truist Financial increased their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Finally, Weiss Ratings raised shares of CVS Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 5th. Twenty-two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $107.24.

CVS Health Trading Down 1.5%

Shares of CVS stock opened at $85.84 on Thursday. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The company has a 50 day moving average price of $97.63 and a 200 day moving average price of $91.51. The stock has a market capitalization of $109.78 billion, a P/E ratio of 22.71, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm's quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health's payout ratio is presently 70.37%.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Polaris Capital Management highlighted CVS’s strengthened second-quarter performance in its global-equity investor letter. CVS’s recent results included better-than-expected earnings and revenue growth, supporting the long-term recovery and growth case. Here’s What Strengthened CVS Health in Q2
• Positive Sentiment: Recent Zacks commentary characterized CVS as a potentially attractive long-term growth stock, with valuation and its broad healthcare platform offering support for investors willing to look beyond near-term volatility. Why CVS Health Is a Top Growth Stock for the Long-Term
• Neutral Sentiment: CVS reminded Tennessee residents that MMR vaccines are available at its pharmacies and MinuteClinics following nine reported measles cases. The announcement may support pharmacy traffic and public-health engagement, but it is unlikely to materially affect earnings. CVS Health Reminds Residents Vaccines Are Available
• Neutral Sentiment: Analyst commentary comparing CVS with Cardinal Health focused on valuation, performance and price targets rather than a new company-specific catalyst, providing context but limited immediate trading impact. CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?
• Neutral Sentiment: CVS launched a nationwide bandage-art contest. The marketing initiative reinforces consumer engagement but is not expected to significantly influence near-term financial results. CVS Launches Wear Your HeART Bandage Art Contest
• Negative Sentiment: Proposed Medicare restrictions on remote patient monitoring could reduce reimbursement or utilization for CVS and raise uncertainty about the business’s outlook. CVS, UnitedHealth and Kaiser are pushing back, but investors may remain cautious until Medicare clarifies the final rules. UnitedHealth, CVS Push Back on Medicare Remote Patient Monitoring Plan

CVS Health Profile

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.